Randomized, investigator blind, vehicle controlled study evalutating the safety, tolerability and pharmacokinetics of E6005 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 25 Nov 2016
At a glance
- Drugs RVT 501 (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions; Pharmacokinetics
- 25 Nov 2016 New trial record